EMS Recovery Effects in Sport Climbing

January 4, 2026 updated by: Akdeniz University

Recovery Effects of Electrical Muscle Stimulation After Climbing-Induced Fatigue: A Randomized Crossover Trial

Sport climbing often requires athletes to perform repeated climbing efforts with short rest periods. Over time, fatigue can build up in the muscles of the arms and forearms, which may reduce performance and increase the difficulty of continuing to climb at the same level.

This study aims to better understand different recovery methods that climbers may use between climbing efforts. Specifically, the study compares two recovery approaches: electrical muscle stimulation-based recovery and passive recovery (resting while seated).

In this study, adult male sport climbers will complete a structured climbing task designed to induce fatigue. After the climbing task, participants will receive one of the two recovery methods. On a separate study visit, they will complete the same procedure using the other recovery method. The order of the recovery methods will be randomized, and there will be a break of one week between sessions.

During the study sessions, researchers will record climbing-related performance measures, simple strength and endurance tasks, heart rate, and how hard the participants feel they are working. The information collected will help researchers better understand recovery strategies used in climbing and may inform training and recovery practices for athletes in the future.

Participation in the study is voluntary, and all procedures are conducted under controlled laboratory conditions.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Sport climbing places high and repetitive demands on the forearm muscles, which are required to sustain repeated gripping and pulling actions with limited recovery time. During prolonged or repeated climbing bouts, local muscular fatigue can accumulate, potentially affecting endurance and movement quality. Competitive climbers are particularly exposed to these demands, as competitions often involve multiple rounds performed within the same day with short rest intervals. For this reason, recovery strategies that can be applied between climbing efforts are of practical relevance in both training and competition settings.

Electrical muscle stimulation (EMS) is a recovery modality that delivers low-intensity electrical impulses to skeletal muscle, producing rhythmic, involuntary contractions. EMS has been used in various sport and rehabilitation contexts as a low-effort method that can be applied without additional mechanical load. However, its application as an inter-bout recovery strategy in sport climbing has not been sufficiently characterized under controlled, climbing-specific conditions.

This study is designed as a randomized crossover trial to compare EMS-based recovery (EMSr) and passive recovery (PASr) following a standardized climbing fatigue protocol. Advanced male sport climbers will participate in two experimental sessions separated by a one-week washout period. In each session, participants will complete the same climbing fatigue protocol, followed by one of the two recovery conditions, with the order of recovery methods randomized.

The fatigue protocol consists of repeated climbing bouts performed on a standardized training wall using a fixed route of defined difficulty. This protocol is intended to elicit localized forearm fatigue under reproducible conditions. Following completion of the fatigue protocol, participants will undergo either EMS applied to the forearm muscles for a fixed duration or passive recovery involving seated rest without additional intervention.

Climbing-related performance measures, muscular endurance tasks, cardiovascular responses, and ratings of perceived exertion will be recorded at predefined time points before and after the recovery period. These measurements are included to characterize physiological and performance-related responses associated with each recovery condition.

The crossover design allows each participant to serve as their own control, thereby reducing inter-individual variability and enabling a direct comparison of recovery approaches under standardized conditions.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
10

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
      • Antalya, Turkey (Türkiye), 07058
        • Akdeniz University Faculty of Sport Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Male climbers aged 30-36 years.
  • At least 3 years of continuous climbing experience, training 3-4 times per week.
  • Ability to climb at least IRCRA grade 15 (French 6a) routes.
  • In good general health and able to safely perform high-intensity climbing.
  • Willing to provide written informed consent and follow study instructions.

Exclusion Criteria:

  • Participation in other sports with high training loads that could interfere with the study.
  • Any injury, medical condition, or musculoskeletal problem that limits climbing performance.
  • Use of medications or supplements that could affect muscle performance or recovery.
  • Inability to comply with study procedures, including the climbing and recovery protocols.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: EMS Recovery (EMSr) Arm
Participants completed a standardized climbing fatigue protocol consisting of 15 sets of 1-minute climbs followed by 1-minute rest on a TensionBoard route (IRCRA grade 15). Immediately after the fatigue protocol, participants underwent Electrical Muscle Stimulation-based Recovery (EMSr). EMS was applied to the forearm flexor muscles (flexor carpi radialis, palmaris longus, flexor carpi ulnaris) using a Chattanooga Wireless Professional 4CH device with 5×5 cm electrodes. The "Active Recovery" program (2-4-6-5-4-3-2-1 Hz; 50 minutes) was used. Stimulation intensity was individually adjusted to elicit visible muscle contraction without discomfort.The EMSr intervention was designed to facilitate local muscle recovery, maintain climbing-specific performance (total move count, isometric hang time), and reduce performance decrements compared to passive rest.
Device: Electrical Muscle Stimulation
This intervention specifically targets the forearm flexor muscles (flexor carpi radialis, palmaris longus, flexor carpi ulnaris) using low-frequency electrical stimulation to promote local muscle recovery after climbing-induced fatigue. The protocol uses a 50-minute "Active Recovery" program (2-4-6-5-4-3-2-1 Hz) applied via a device, with intensity individually adjusted to elicit visible muscle contraction without discomfort. Unlike general active recovery or passive rest, this intervention provides localized neuromuscular stimulation designed to preserve climbing-specific performance metrics such as total move count and weighted isometric hang time.
No Intervention: Passive Recovery (PASr) Arm

Participants completed the same standardized climbing fatigue protocol (15 × 1-minute climbs with 1-minute rest on a TensionBoard route, IRCRA grade 15). Immediately after the fatigue protocol, participants underwent passive recovery (PASr), consisting of 50 minutes of seated rest. No active muscle stimulation or exercise was performed during this period.

The PASr arm serves as a control condition to evaluate the effects of EMS-based recovery on climbing-specific performance metrics.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Change from Baseline in Total Move Count During the TensionBoard Fatigue Test Following Recovery Intervention
Time Frame: Immediately after the 50-minute recovery period following the fatigue protocol.
Total move count represents the number of hand movements completed by each participant during the TensionBoard Fatigue Test, which consists of 15 sets of 1-minute climbs with 1-minute rests on a standardized route (IRCRA grade 15). This measure assesses climbing-specific performance and endurance, reflecting the ability to sustain high-intensity climbing efforts after the fatigue protocol. Move count is recorded for each set, and the change from baseline (pre-recovery) to post-recovery is used to evaluate the effectiveness of the intervention (EMS recovery vs. passive rest).
Immediately after the 50-minute recovery period following the fatigue protocol.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Akdeniz University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 10, 2020

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
January 10, 2021

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
July 10, 2021

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
December 17, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 4, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
January 13, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
January 13, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 4, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
November 1, 2020

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • TSA-2019-4786

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified individual participant data (IPD) from this study, including climbing performance metrics, recovery protocol details, and anthropometric measurements, will be made available to other researchers upon reasonable request. Requests should be submitted to the corresponding author (Tuba Melekoğlu, tmelekoglu@akdeniz.edu.tr) and will require a data use agreement outlining the purpose of analysis, protection of participant confidentiality, and acknowledgment of the original study. Data will be available for academic and non-commercial research purposes for 5 years following publication of the study results.

IPD Sharing Time Frame

Start Date: Upon publication of the study results (estimated June 2026) End Date: 5 years after publication (estimated June 2031)

IPD Sharing Access Criteria

Who can access: Qualified researchers from academic or non-commercial research institutions who submit a reasonable request and agree to a data use agreement.

What they can access: De-identified individual participant data, including climbing performance metrics (total move count, isometric hang time, push-up and sit-up performance), anthropometric measurements, and details of the recovery protocols (EMS and passive recovery). Supporting documentation, such as the study protocol and data dictionaries, will also be provided.

How they can access: Requests must be submitted to the corresponding author (Tuba Melekoğlu, tmelekoglu@akdeniz.edu.tr). Upon approval and signing of a data use agreement, datasets and supporting information will be shared electronically in a secure format.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise-Induced Fatigue

Clinical Trials on Electrical Muscle Stimulation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings